Secondary Prevention Medications
Cross-source consensus on Secondary Prevention Medications from 1 sources and 7 claims.
1 sources · 7 claims
Risks & contraindications
Background
Evidence quality
Highlighted claims
- Antihypertensive dispensing remains below 50% in both ischaemic and haemorrhagic stroke despite clinical evidence supporting a target systolic blood pressure of 125 mmHg or lower. — Measurement of quality of stroke care with national electronic health records: a prospective cohort study during and after the COVID-19 pandemic
- Only 77.1% of patients with pre-existing atrial fibrillation and ischaemic stroke received an anticoagulant within one year, falling below guideline expectations. — Measurement of quality of stroke care with national electronic health records: a prospective cohort study during and after the COVID-19 pandemic
- The gap in antihypertensive prescribing predates and persists through the COVID-19 pandemic, confirming it is a structural rather than crisis-related problem. — Measurement of quality of stroke care with national electronic health records: a prospective cohort study during and after the COVID-19 pandemic
- Antiplatelet and anticoagulant dispensing rates were stable across 2020 to 2023. — Measurement of quality of stroke care with national electronic health records: a prospective cohort study during and after the COVID-19 pandemic
- Older patients were significantly less likely to receive lipid-lowering or antihypertensive medication after adjustment, but age did not affect anticoagulant or antiplatelet dispensing. — Measurement of quality of stroke care with national electronic health records: a prospective cohort study during and after the COVID-19 pandemic
- Antihypertensive and lipid-lowering dispensing increased modestly over the study period, suggesting gradual quality improvement. — Measurement of quality of stroke care with national electronic health records: a prospective cohort study during and after the COVID-19 pandemic
- EHR dispensing data cannot capture clinical contraindications, patient frailty, or end-of-life decisions, so lower dispensing rates may partly reflect appropriate clinical decision-making. — Measurement of quality of stroke care with national electronic health records: a prospective cohort study during and after the COVID-19 pandemic